Summary
  • Multi-target molecules 53
  • Clinical molecules 0
  • Avg pChEMBL 8.29
Top Co-occurrence Targets
Active Molecules (53)
InChIKey pChEMBL Type Targets Clinical
YWYUGJWEIJQUGR 9.3 IC50 3
YQSZHQDSWAVRIF 9.1 IC50 3
YUXCQMTZGXAHRI 9.1 IC50 3
WJEOOIPQOGUUDR 9.0 IC50 3
YUACNGPAVKFBDY 8.9 IC50 3
QRSITDRGDCGFJI 8.8 IC50 3
ZDMNTLDIWOJOTP 8.8 IC50 3
VTLCWLDIFFWTOF 8.7 IC50 3
XLKNMMCECCXSPF 8.7 IC50 3
IQVIVUQYANERMA 8.7 IC50 3
IJVIWBPQCWTULC 8.6 IC50 3
GZNSYXMPMHSIDC 8.6 IC50 3
JEXBFVYJJWHBRA 8.6 IC50 3
XRRYEGIOXDSKKH 8.6 IC50 3
RYDNCFIKBUUTTO 8.6 IC50 3
MKUFAWDAPBDDKS 8.6 IC50 3
YEXVOZNCLYKDPL 8.6 IC50 3
DLORRRHWKGMQHQ 8.6 IC50 3
PCWBICPLNKRDCZ 8.6 IC50 3
GMEFFYBNYGJWMY 8.5 IC50 3
HOXBFIPKPBODHA 8.5 IC50 3
OAMLETSZKAKGGK 8.5 IC50 3
MFARMFXLOUWZSG 8.5 IC50 3
SOAJNGWSIIAAQL 8.4 IC50 3
FJOFDNLXSMNNHW 8.4 IC50 3
HOXBFIPKPBODHA 8.4 IC50 3
JDZTXOGPJRNYGP 8.4 IC50 3
CZUVUFBVPYMXTN 8.4 IC50 3
HHVKSVZYOCLGOE 8.4 IC50 3
HWJUUAFPZKKFST 8.4 IC50 3
WBABIWUULPNBAQ 8.3 IC50 3
HOZOPPUBYQVCPM 8.2 IC50 3
ZVXVQIHRFHHKDO 8.2 IC50 3
BNSTVDKRZVYCPF 8.2 IC50 3
WUWSRFYMNKHGQF 8.2 IC50 3
LHNFLUITCYRERV 8.1 IC50 3
FDLWQSXUTCMNTD 8.1 IC50 3
PYIFPEMCGLTYNR 8.1 IC50 3
CKZVXLOLDQZGKK 8.0 IC50 3
GTHBXRNHLULRRM 8.0 IC50 3
MTWFVSKQCZUCRY 7.9 IC50 3
IWSVGSLKZVMQJR 7.9 IC50 3
VZQBLIGJOFRBEW 7.8 IC50 3
YTOCFEHRXHCGHM 7.8 IC50 3
DOEZXCZJNCFNGG 7.8 IC50 3
JYUHMSQBLWDSTO 7.7 IC50 2
RZXQBIKGWSLVEK 7.6 IC50 2
VUSOSFZGBGAREA 7.4 IC50 3
KKRCNFSDAPQTMV 7.4 IC50 3
SPAZLRZRWNMBFN 7.4 IC50 3
2D structure